Showing 12 posts of 12 posts found.


Women who take statins could be less likely to develop ovarian cancer, study finds

February 19, 2020
Research and Development, Sales and Marketing Cancer, Cancer Research UK, cholesterol, ovarian cancer, statins

A study by Cancer Research UK has found that women who take statins, drugs that lower cholesterol, are less likely …

Half of patients have sub-optimal response to statins, research shows

April 16, 2019
Manufacturing and Production NHS, NICE, NICE guidelines, cholesterol, health, statins

Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, …


New class of drugs offer alternative to statins

March 14, 2019
Research and Development cholesterol, health, imperial college london, research, statins

A new class of cholesterol lowering drugs may help patients who are unable to take statins, according to a study …


Research may unlock statins cancer-fighting ability

July 17, 2017
Research and Development, Sales and Marketing Keele University, biotech, drugs, pharma, pharmaceutical, statins

Many previous studies have shown that statins are able to have an impact on cancer cells but the results have …


£6 million statin study to determine potential therapeutic use in MS

May 9, 2017
Manufacturing and Production, Research and Development multiple sclerosis, statins

A large study will take place in the UK to determine whether statins, commonly prescribed to combat “bad cholesterol”, are …


Statins revealed to potentially aid cancer treatment

January 25, 2017
Research and Development Cancer, University of Kansan, statins

New research, conducted at the University of Kansas, has emerged that reveal a potential use for statins beyond their current …


Amgen’s high cholesterol drug at centre of patent court case yields positive clinical trial results

April 4, 2016
Research and Development, Sales and Marketing Amgen, Repatha, Sanofi, high cholesterol. ldl, ldl-c, phase III, statins

Amgen has announced positive results from the Phase III GAUSS-3 clinical trial evaluating Repatha (evolucumab) in patients with high cholesterol …

Sanofi image

Sanofi and Regeneron post positive alirocumab results

January 9, 2015
Sales and Marketing Regeneron, Sanofi, cholesterol, heart, statin, statins

The latest trials of the potentially blockbuster new heart drug alirocumab show it lowers cholesterol in people at moderate and …

UK doctors are ignoring statin guidance

November 3, 2014
Sales and Marketing British Medical Association, GPs, NHS, NICE, Royal College of GPs, Royal College of Physicians, statins

A survey of UK doctors has found that many are refusing to apply NICE advice to offer statin therapy to …

Amgen image

Amgen submits next gen cholesterol drug

August 29, 2014
Sales and Marketing Amgen, FDA, PCSK9, Regeneron, Sanofi, statins

Amgen has put itself in pole position in the race to market the next generation of injectable statins known as …

Statins image

Researchers question ‘bias’ NICE on statins

June 11, 2014
Sales and Marketing Drug pricing, Haslam, NHS, NICE, statins

Doctors are warning that NICE’s desire to increase prescriptions of statins in England is based on pharma-funded research that ignores …

NICE image

NICE: ‘Use more statins’

February 12, 2014
Sales and Marketing NHS, NICE, baker, cvd, statins

NICE has decided more NHS patients ought to be considered at risk of cardiovascular disease (CVD) – and therefore advises …

Latest content